The COVID Project
The record
- Jurisdiction
- United States (federal); Substance Abuse and Mental Health Services Administration
- Level
- Federal
- Authority
- 42 C.F.R. 8.11(h), 8.12(i)
- Issued
- 2020-03-16 Mar. 16, 2020
- Effective
- 2020-03-16 (updated Mar. 19, 2020) (read as 2020-03-16)
- End
- Extended Nov. 18, 2021 for one year past the PHE; superseded by the final rule effective Apr. 2, 2024 (read as 2021-11-18)
- In force
- Mar. 16, 2020 to Nov. 18, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Health care ordersOther
- Addressees
- State opioid treatment authorities
- opioid treatment programs
- Functions reached
- CL clinical dosing
- FD scheduling
- WF workforce (quarantined patients and staff)
- CB patients
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
FOR ALL STATES The state may request blanket exceptions for all stable patients in an OTP to receive 28 days of Take-Home doses of the patient's medication for opioid use disorder. The state may request up to 14 days of Take-Home medication for those patients who are less stable but who the OTP believes can safely handle this level of Take-Home medication.
Enforcement
Exemption from 42 C.F.R. 8.12(i) conditions; OTP certification
Notes
The instrument SAMHSA's Nov. 18, 2021 guidance recites as the March 16, 2020 exemption.